Non-inferiority
A trial design that checks whether a new treatment is 'not worse' than an existing one by more than an agreed small amount.
Also called: noninferior, non-inferior, noninferiority
Related words head-to-head trial
Topics Research
A trial design that checks whether a new treatment is 'not worse' than an existing one by more than an agreed small amount.
Also called: noninferior, non-inferior, noninferiority
Related words head-to-head trial
Topics Research
A head-to-head trial in people whose Crohn's had not responded to, or who could not tolerate, anti-TNF drugs. Risankizumab (Skyrizi) was at least as good as ustekinumab (Stelara) for remission at 24 weeks and better at healing the bowel lining by 48 weeks. Side effects looked similar.
Topics Biologics and newer medicines Research
Jargon explained non-inferiority endoscopic remission anti-TNF
Covers the common skin cancers that are not melanoma, such as basal cell and squamous cell carcinoma: what to look out for (a lump or patch that does not heal), when to see a GP, causes including sun exposure, and how to lower your risk. Relevant because some Crohn's medicines raise skin cancer risk slightly.
Topics Cancer risk and screening
Jargon explained non-melanoma skin cancer basal cell carcinoma squamous cell carcinoma
One of the first 'head-to-head' trials comparing two biologics directly, in people who had never had a biologic. At one year, about 65% on ustekinumab and 61% on adalimumab were in remission, a difference too small to matter. Both worked well, so the choice between them can depend on other things such as preference and how the drug is given.
Topics Biologics and newer medicines Research
Jargon explained head-to-head trial biologic-naive confidence interval
A Cochrane review of 75 trials of medical treatments for anal fissure, such as GTN ointment, calcium channel blocker creams and botox. Medicines helped some fissures heal but less reliably than surgery, and fissures often came back. Fissures linked to IBD were excluded, so results may not fully apply to Crohn's.
Topics Around the bottom (perianal) Research
Jargon explained anal fissure glyceryl trinitrate sphincterotomy
An overview of UK disability and sickness benefits for adults, children and carers affected by Crohn's or Colitis. It explains the difference between means-tested and non-means-tested benefits, notes the rules differ across the four nations, and recommends benefits calculators and local advice services.
Topics Work, school and benefits
Jargon explained means-tested non-means-tested carer's allowance
A guide to mirikizumab (Omvoh), a biologic that blocks the IL-23 protein. It explains the starting doses by drip followed by injections under the skin if it works, vaccine advice, and side effects.
Topics Biologics and newer medicines
Jargon explained IL-23 interleukin inhibitor non-live vaccine
A young man with small-bowel Crohn's coughed up a large amount of blood and needed emergency lung surgery. The removed lung tissue showed the same kind of inflammation seen in Crohn's. The authors argue it was Crohn's affecting the lung rather than sarcoidosis, a rare but recognised complication.
Topics Beyond the gut Complications
Jargon explained haemoptysis sarcoidosis non-caseating granuloma lobectomy
Practical ways to lower the risks of medicines that suppress the immune system. You should not have live vaccines while on an immunosuppressant, but non-live vaccines such as the injected flu jab, COVID-19, Shingrix shingles and pneumococcal vaccines are safe. It explains checks for chickenpox immunity, the slightly raised risk of some cancers, especially skin cancer, and sun safety, plus food hygiene and travel precautions.
Topics Immunosuppressants Vaccinations and infections Cancer risk and screening Travel Biologics and newer medicines
Jargon explained immunosuppressant live vaccine non-live vaccine Shingrix pneumococcal vaccine JAK inhibitor anti-TNF